Shree Ganesh Bio-Tech P/E Ratio
Shree Ganesh Bio-Tech (SHREEGANES) P/E ratio is 69.0 (High), EPS (TTM) ₹0.01, current price ₹0.69 on BSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Shree Ganesh Bio-Tech share price chart.
Current P/E Ratio
69.0
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
69.0
Current Price
₹0.69
EPS (TTM)
₹0.01
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.25
Sector Median
27.32
Sector Rank
#11 of 140
Sector Percentile
7.9%
SHREEGANES P/E Ratio — Valuation Signal & Historical Context
Shree Ganesh Bio-Tech P/E 69.0 — signal: Overvalued. Analyse SHREEGANES ownership pattern to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 69.0, suggesting caution for new investments
- Trading at premium to sector average PE of 49.25
SHREEGANES vs Healthcare Peers — P/E Ratio Comparison
Shree Ganesh Bio-Tech P/E 69.0 vs Healthcare average 49.25, median 27.32 — range 1.17–869.57.
Sector Average
49.25
Sector Median
27.32
Lowest P/E
1.17
Highest P/E
869.57
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 6.78 | ₹73 | Low |
| Zenith Drugs | ZENITHDRUG | 7.55 | ₹73 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Medicamen Organics | MEDIORG | 8.01 | ₹32 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Vasundhara Rasayans | VRL | 11.05 | ₹40 | Low |